EVGN Evogene Ltd.: institutional ownership and insider trading
13 funds reported holding $116K of Evogene Ltd. in their latest 13F filings; in Q2 2026 funds net sold $109K, with 3 new positions and 5 funds selling out; over the last 12 months insiders bought $695K and sold $0 on the open market.
Famous investors holding EVGN
- Ken Griffin (Citadel Advisors): $21.4K, 0.0% of the portfolio
Largest institutional holders of EVGN
- HRT FINANCIAL LP — $45.0K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $33.9K
- CITADEL ADVISORS LLC — $21.4K
- XTX Topco Ltd — $8.21K
- UBS Group AG (UBS) — $4.74K
- BNP PARIBAS FINANCIAL MARKETS — $1.24K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $564
- Federation des caisses Desjardins du Quebec — $220
- Daytona Street Capital LLC — $208
- OSAIC HOLDINGS, INC. — $44
Recent EVGN insider trades
- Aug 11, 2026: Recanati Leon bought 460,000 shares ($294K)
- Aug 4, 2026: Recanati Leon bought 800,000 shares ($400K)
- Jun 4, 2026: Tarcic Gabi bought 1,129 shares ($677)
5%+ owners
- L.I.A. Pure Capital Ltd.: 16.9% (Schedule 13D/A, filed Oct 6, 2026)
- RECANATI LEON: 8.6% (Schedule 13D/A, filed Sep 11, 2026)